Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial

Patrick Y. Wen

Donald A. Berry

Berry Consultants, LLC, Austin, TX

Meredith B. Buxton

Global Coalition for Adaptive Research, Larkspur, CA

Howard Colman

John de Groot

University of California San Francisco, San Francisco, CA

Michael Lim

Ingo Mellinghoff

3Memorial Sloan Kettering Cancer Center, New York, United States

James R. Perry

Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada

Michael Weller

Nicholas A. Blondin

Yale University, New Haven, CT

Omar H. Butt

Denise M. Damek

University of Colorado School of Medicine, Aurora, CO

Macarena I. De La Fuente

Jan Drappatz

22Department of Neurology and Medicine, University of Pittsburgh, Pittsburgh, PA

Erin Dunbar

Piedmont Brain Tumor Center, Atlanta, GA

Pierre Giglio

The Ohio State University Wexner Medical Center, Columbus, OH

Emma Viktoria Hyddmark

Global Coalition for Adaptive Research, Larkspur, CA

Fabio Iwamoto

Columbia University Irving Medical Center, New York, NY

Kurt A. Jaeckle

Mayo Clinic Florida, Jacksonville, FL

Lyndon Kim

Icahn School of Medicine at Mount Sinai, New York, NY

Heather M. Kling

Global Coalition for Adaptive Research, Larkspur, CA

Eudocia Q. Lee

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA

Megan Mantica

University of Pittsburgh Medical Center, Pittsburgh, PA

Tom Mikkelsen

Burt Nabors

University of Alabama at Birmingham, Birmingham, AL

Herbert B. Newton

University Hospitals Cleveland Medical Center & Seidman Cancer Center, Cleveland, OH

Jeffrey J. Olson

Emory University School of Medicine, Atlanta, GA

David Schiff

31Department of Neurology, Division of Neuro-Oncology, University of Virginia, Charlottesville, VA

Tobias Walbert

Henry Ford Health, Michigan State and Wayne State University, Detroit, MI

Shiao-Pei Weathers

Timothy Cloughesy

University of California Los Angeles, Global Coalition for Adaptive Research, Los Angeles, CA

Andrew B. Lassman

Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York-Presbyterian, New York, NY